Rosetta Genomics (NASDAQ:ROSG) today announced that the United States Patent and Trademark Office has allowed claims in two patent applications. The first, covering human microRNA miR-21, was derived from the "Tuschl III" patent series that is assigned to the Max Planck Society, Berlin, Germany and is used in Rosetta's miRview™ mets and miRview™ squamous diagnostic assays. Rosetta holds a co-exclusive license to miR-21 in diagnostic applications, and a non-exclusive license for the research use field...
More...
iHav.net - Your Uncensored Offtopic Community
If this is your first visit, please click the Sign Up now button to begin the process of creating your account so you can begin posting on our forums! The Sign Up process will only take up about a minute of two of your time.
|
|
|
Results 1 to 1 of 1
-
02-01-2010, 01:01 PM #1Senior Member
- Join Date
- Mar 2008
- Posts
- 12,518
- Downloads
- 0
- Uploads
- 0
Rosetta Genomics Fortifies Patent Position With U.S. Allowance Of Claims Covering Hum
Reply With QuoteSimilar Threads
-
Rosetta Genomics Fortifies Patent Position With U.S. Allowance Of Claims Covering Hum
By ! D33NA ! in forum Health and FitnessReplies: 0Last Post: 02-01-2010, 01:00 PM -
What is the difference between PFO (patent foramen ovale) and PDA (patent ductus
By CP M in forum Pda/SmartphoneReplies: 4Last Post: 04-09-2009, 07:58 PM -
What is the difference between PFO (patent foramen ovale) and PDA (patent ductus
By CP M in forum Pda/SmartphoneReplies: 0Last Post: 04-09-2009, 07:57 PM -
Dissecting Apple's "Multitouch" Patent: Can It Stop Palm? [Patent Wars]
By Geek in forum NewsReplies: 0Last Post: 01-30-2009, 03:00 PM -
Comcast claims not to be blocking P2P traffic, but Utorrent port checker claims the
By Eric K in forum File SharingReplies: 0Last Post: 12-12-2007, 12:23 AM
Bookmarks